Stephen Johnson

Array ( [id] => 6014729 [patent_doc_number] => 20110223126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'OPHTHALMIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/112549 [patent_app_country] => US [patent_app_date] => 2011-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13221 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223126.pdf [firstpage_image] =>[orig_patent_app_number] => 13112549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710841 [patent_doc_number] => 08835410 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Treatment of eyelid dermatitis' [patent_app_type] => utility [patent_app_number] => 13/104846 [patent_app_country] => US [patent_app_date] => 2011-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9399 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13104846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685090 [patent_doc_number] => 20130053374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'OPHTHALMIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/695930 [patent_app_country] => US [patent_app_date] => 2011-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 18872 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10600175 [patent_doc_number] => 09320723 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Methods of treating thyroid eye disease' [patent_app_type] => utility [patent_app_number] => 13/099991 [patent_app_country] => US [patent_app_date] => 2011-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 41 [patent_no_of_words] => 20131 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13099991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573131 [patent_doc_number] => 20110268787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Ocular compositions containing dioleoylphosphatidylglycerol and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/068007 [patent_app_country] => US [patent_app_date] => 2011-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7849 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268787.pdf [firstpage_image] =>[orig_patent_app_number] => 13068007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6064574 [patent_doc_number] => 20110201692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'ANTIMICROBIAL FLUSH SOLUTIONS' [patent_app_type] => utility [patent_app_number] => 13/095262 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12368 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201692.pdf [firstpage_image] =>[orig_patent_app_number] => 13095262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10141069 [patent_doc_number] => 09173856 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Therapeutic regimen and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency' [patent_app_type] => utility [patent_app_number] => 13/090215 [patent_app_country] => US [patent_app_date] => 2011-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23102 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13090215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7502052 [patent_doc_number] => 20110263717 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Ophthalmic Compositions with Biguanide and PEG-Glycerol Esters' [patent_app_type] => utility [patent_app_number] => 13/072998 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7638 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263717.pdf [firstpage_image] =>[orig_patent_app_number] => 13072998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019932 [patent_doc_number] => 08529915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => '(R)-(-)-1,2-propanediol compositions and methods' [patent_app_type] => utility [patent_app_number] => 13/065185 [patent_app_country] => US [patent_app_date] => 2011-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6000 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13065185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087658 [patent_doc_number] => 20110217202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'ACTIVE OXYGEN DISINFECTION SYSTEM AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/041466 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9700 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217202.pdf [firstpage_image] =>[orig_patent_app_number] => 13041466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972943 [patent_doc_number] => 20110152307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'OPHTHALMIC COMPOSITION COMPRISING ASCOMYCIN' [patent_app_type] => utility [patent_app_number] => 13/037399 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3446 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152307.pdf [firstpage_image] =>[orig_patent_app_number] => 13037399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11886790 [patent_doc_number] => 09757338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-12 [patent_title] => 'Sustained-release donepezil formulation' [patent_app_type] => utility [patent_app_number] => 13/036010 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5552 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 164 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13036010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016915 [patent_doc_number] => 20110224268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'Compositions and methods of using R(+) pramipexole' [patent_app_type] => utility [patent_app_number] => 12/932540 [patent_app_country] => US [patent_app_date] => 2011-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19092 [patent_no_of_claims] => 86 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224268.pdf [firstpage_image] =>[orig_patent_app_number] => 12932540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6048816 [patent_doc_number] => 20110207809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD OF ACCELERATING CORNEAL WOUND HEALING' [patent_app_type] => utility [patent_app_number] => 13/034889 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3441 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207809.pdf [firstpage_image] =>[orig_patent_app_number] => 13034889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6186636 [patent_doc_number] => 20110124680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'NOVEL ANTHRANILAMIDE PYRIDINUREAS AS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/019530 [patent_app_country] => US [patent_app_date] => 2011-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12727 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124680.pdf [firstpage_image] =>[orig_patent_app_number] => 13019530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581715 [patent_doc_number] => 08771715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Compositions and methods for treatment' [patent_app_type] => utility [patent_app_number] => 13/011760 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33817 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9551731 [patent_doc_number] => 08758776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-24 [patent_title] => 'Compositions and methods for treatment' [patent_app_type] => utility [patent_app_number] => 13/011775 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 33816 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13011775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8313635 [patent_doc_number] => 20120190653 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'THERAPEUTIC EYE DROP COMPRISING DOXYCYCLINE AND A STABILIZER' [patent_app_type] => utility [patent_app_number] => 13/009935 [patent_app_country] => US [patent_app_date] => 2011-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7034 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009935 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055706 [patent_doc_number] => 20110112066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'PREVENTIVE/REMEDY FOR RETINAL NERVE DISEASES CONTAINING ALKYL ETHER DERIVATIVES OR SALTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/008982 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30249 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112066.pdf [firstpage_image] =>[orig_patent_app_number] => 13008982 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502070 [patent_doc_number] => 20120301478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular Permeability' [patent_app_type] => utility [patent_app_number] => 13/521395 [patent_app_country] => US [patent_app_date] => 2011-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6198 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13521395 [rel_patent_id] =>[rel_patent_doc_number] =>)